| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gastric Diffuse large B‐cell lymphoma (DLBCL) is the most common
extranodal site of lymphoma's involvement (30%-40% of all extranodal
lymphomas and 55%-65% of all gastrointestinal lymphomas). However,
gastric localizations are also sometimes found in systemic DLBCL.
Gastric complications such as bleeding, perforation, and stenosis under
chemotherapy are well documented.
1. Characteristics of Population.
|Table 2. Diagnostic test results.
|Figure 1. EGDS from one of
the patients with gastric ulcer. Before (Left) and After (Right)
Cyclophosphamide chemotherapy pre-phase.
|Table 3. Efficacy of Low-dose pre-phase chemotherapy.
|Table 4. Response Rates.
|Table 5. Treatment-related toxicity.
Compliance with Ethical Standards